Krathish Bopanna

Dr. Krathish Bopanna

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2025 in Indian Journal of Pharmacology
Verified
Journal Article
Open access
SMS Mehkri
S Mehkri
KDK. G. Dinesh
K. G. Dinesh
GAG. Ashok
G. Ashok
Krathish BopannaKrathish Bopanna
Krathish Bopanna
BACKGROUND: Palmitoylethanolamide (PEA) is an endogenous fatty acid amide signaling molecule that may indirectly modulate the endocannabinoid system. It has poor water solubility and, therefore, is not readily absorbed in the human body. Various formulation techniques have been developed to enhance the rate of dissolution of PEA and minimize the variability of drug absorption when administered orally. The present study compared the pharmacokinetics (PKs) of two different grades of micronized PEA, a water-dispersible PEA, and standard PEA in male Sprague–Dawley rats, following a single oral administration. MATERIALS AND METHODS: The drug PKs of each form of PEA-micronized (PEA-10µm), micronized PEA 6 µm (PEA-6 µm), and water-dispersible PEA (PEA-WD), were assessed and compared against a standard nonmicronized PEA (PEA-nm) using male Sprague–Dawley rats after a single dose oral administration. PEA plasma concentration (ng/mL) across all groups was determined using the liquid chromatography with tandem mass spectrometry method. RESULTS: PEA supplementation significantly increased the total area under curve (AUC) in all the groups compared to PEA-nm, with PEA-WD ( P < 0.001) exhibiting an exceptionally large effect of > 16 times. In addition, the PEA supplementation raised the maximum concentration (C max ) from the baseline in all the groups. When C max for each group was compared against PEA-nm at a probability level of 0.05, PEA-10 µm indicated no statistically significant difference ( P = 0.060), whereas PEA-6 µm ( P < 0.001) and PEA-WD ( P < 0.001) displayed a statistically significant difference at the aforesaid probability level. CONCLUSION: PEA-WD demonstrated a higher total AUC and C max , followed by PEA-6 µm and PEA-10 µm compared to nonmicronized form of PEA. This indicates greater bioavailability of water-dispersible PEA, thus making it a promising candidate for enhancing clinical outcomes.

1 January 2022 in International Journal of Ophthalmology Research
Verified
Journal Article
Closed access
SMS Mehkri
S Mehkri
MTM B Thirumalesh
M B Thirumalesh
MKM V Krishnaiah
M V Krishnaiah
GAG Ashok
G Ashok
Krathish BopannaKrathish Bopanna
Krathish Bopanna
Levels of the macular xanthophylls lutein, zeaxanthin and other carotenoids have been associated with slower progression of age-related macular degeneration potentially through their action by quenching reactive oxygen species, scavenging blue light and thereby protecting the eye from photo-oxidative damage. The objective of this clinical study was to assess the effect of Lutein and Zeaxanthin (Lute-gen®) supplementation, with and without natural mixed carotenoids on macular pigment optical density (MPOD) in healthy adult subjects. A total of 93 subjects were randomized in a double blind, placebo controlled, parallel, three arm study which was followed up for 180 days. Subjects who met the inclusion criteria underwent general physical and ophthalmic examinations. Further, study specific macular pigment optical density (MPOD) was assessed through macular assessment Profile (MAP) test. Data obtained post study period were subjected to advanced statistical analysis to determine efficacy of Lutein and Zeaxanthin (Lute-gen®) with and without natural mixed carotenoids on macular pigment optical density (MPOD). Lutein and Zeaxanthin (Lute-gen®) supplementation, with natural carotenoids (P=0.0009) and without natural mixed carotenoids (P=0.0001) showed statistically significant improvements in the MPOD levels when compared to baseline from the last visit. On the other hand, the placebo arm (P=0.6179) did not show any significant change in MPOD levels. It can be concluded that higher levels of MPOD may reduce the risk of age-related macular degeneration (AMD) and provide necessary protection against oxidative damage and blue-light.

2 December 2025 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
SMS. Mehkri
S. Mehkri
KDK. G. Dinesh
K. G. Dinesh
AGAshok Godavarthi
Ashok Godavarthi
Krathish BopannaKrathish Bopanna
Krathish Bopanna
Background: Lutein and zeaxanthin (LZ) are macular xanthophyll carotenoids with antioxidant and blue-light filtering properties, but their oral bioavailability is limited. Lipid-based delivery systems may enhance absorption. Methods: We compared four single-dose LZ delivery systems in male Sprague–Dawley rats: (G1) LZ in medium-chain triglyceride (MCT) oil; (G2) LZ in MCT + phosphatidylcholine (PC); (G3) LZ in MCT + phosphatidylserine (PS); (G4) LZ in liposomal powder. Following an overnight fast, each group (n = 6) received an oral gavage of the assigned formulation. Serial blood samples were collected up to 24 h post-dose. Plasma lutein + zeaxanthin concentrations were quantified by a validated LC–MS/MS method. Non-compartmental pharmacokinetic (PK) parameters were computed (Phoenix WinNonlin®), and one-way ANOVA was used to make inter-group comparisons on ln-transformed metrics with Dunnett’s post hoc tests. Results: The PS-complexed formulation (G3) yielded the highest LZ exposure (mean C_max 69.63 ± 0.78 ng/mL; AUC_0-t 620.23 ± 16.41 ng·h/mL), significantly exceeding the MCT oil control (G1: 52.54 ± 0.70 ng/mL; 494.51 ± 13.70 ng·h/mL; p < 0.001). The PC-enriched oil (G2) and liposomal powder (G4) also produced higher C_max and AUC than G1 (p < 0.01). No differences in elimination half-life (t1/2 ≈ eight h) were observed between formulations. Conclusions: Phospholipids, especially PS, substantially improved the systemic availability of lutein and zeaxanthin compared with MCT oil alone. PS-based lipid complexes appear particularly effective, supporting their use in ocular-health formulations to maximise xanthophyll bioavailability.

21 October 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
MSMehkri S.
Mehkri S.
DGDinesh K. G.
Dinesh K. G.
AGAshok Godavarthi
Ashok Godavarthi
Krathish BopannaKrathish Bopanna
Krathish Bopanna
Background: Lutein and zeaxanthin (LZ) are macular xanthophyll carotenoids with antioxidant and blue-light filtering properties, but their oral bioavailability is limited. Lipid-based delivery systems may enhance absorption. Methods: We compared four single-dose LZ delivery systems in male Sprague–Dawley rats: (G1) LZ in medium-chain triglyceride (MCT) oil; (G2) LZ in MCT + phosphatidylcholine (PC); (G3) LZ in MCT + phosphatidylserine (PS); (G4) LZ in liposomal powder. Following an overnight fast, each group (n = 6) received an oral gavage of the assigned formulation. Serial blood samples were collected up to 24 h post-dose. Plasma lutein + zeaxanthin concentrations were quantified by a validated LC–MS/MS method. Non-compartmental pharmacokinetic (PK) parameters were computed (Phoenix WinNonlin®), and one-way ANOVA was used to make inter-group comparisons on ln-transformed metrics with Dunnett’s post hoc tests. Results: The PS-complexed formulation (G3) yielded the highest LZ exposure (mean C_max 69.63 ± 0.78 ng/mL; AUC_0-t 620.23 ± 16.41 ng·h/mL), significantly exceeding the MCT oil control (G1: 52.54 ± 0.70 ng/mL; 494.51 ± 13.70 ng·h/mL; p < 0.001). The PC-enriched oil (G2) and liposomal powder (G4) also produced higher C_max and AUC than G1 (p < 0.01). No differences in elimination half-life (t1/2 ≈ 8 h) were observed between formulations. Conclusions: Phospholipids, especially with PS, substantially improve lutein and zeaxanthin systemic availability versus MCT oil alone. PS-based lipid complexes appear particularly effective, supporting their use in ocular-health formulations to maximise xanthophyll bioavailability.

15 June 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Krathish BopannaKrathish Bopanna
Krathish Bopanna
DKDinesh Kg
Dinesh Kg
SMS Mehkri
S Mehkri
Berberine, a plant-derived isoquinoline alkaloid, is widely recognised for its hypoglycaemic, hypolipidaemic, and insulin-sensitising effects; however, its clinical use is limited by poor oral bioavailability, driven by low aqueous solubility, intestinal P-glycoprotein–mediated efflux, and extensive first-pass metabolism. Emerging evidence suggests that berberine’s pharmacological activity may be more closely linked to tissue exposure in metabolically active organs than to systemic plasma concentrations alone. In this study, the effects of formulation strategies on the plasma pharmacokinetics and tissue distribution of berberine were evaluated using lipid-based and surfactant-assisted formulations. After oral administration to rats, plasma and tissue concentrations (liver, intestine, and brain) were quantified using a validated LC–MS/MS method, and pharmacokinetic parameters were determined by noncompartmental analysis. Among all formulations, the lipid-encapsulated formulation significantly increased tissue exposure, yielding approximately 1.75-fold higher hepatic and 1.60-fold higher intestinal concentrations than standard berberine, along with statistically significant increases in systemic exposure. Increased tissue exposure in these metabolically relevant organs may be linked to berberine’s reported effects on hepatic metabolism and intestinal signalling pathways. Despite these improvements, brain concentrations remained low across all formulations, indicating limited penetration of the blood–brain barrier. Overall, the findings support the concept that tissue-specific pharmacokinetics may provide additional insight into berberine’s metabolic activity beyond plasma concentrations alone, and highlight the importance of formulation strategies that enhance organ-specific exposure.

1 January 2023 in International Journal of Ophthalmology Research
Verified
Journal Article
Closed access
SMS Mehkri
S Mehkri
MTMb Thirumalesh
Mb Thirumalesh
MKMv Krishnaiah
Mv Krishnaiah
GAG Ashok
G Ashok
Krathish BopannaKrathish Bopanna
Krathish Bopanna
The fovea is a specialised part of the retina which accumulates macular carotenoids. Isomeric carotenoids like lutein, zeaxanthin and meso-zeaxanthin with antioxidant properties are the principal components of macular pigment (MP) accounting for the yellowish colour of the macular area of the retina. MP blocks short wavelength (blue) light that would otherwise damage photoreceptors and pigment epithelial cells causing irreversible changes to the eye architecture. The concentration of MP peaks at the fovea and is visible on the inner and outer plexiform layers of the parafoveal area, thereby protecting retinal damage, which is measured through the relationship between CFT (central foveal thickness) and MPOD (macular pigment optical density). The objective of this clinical study was to assess the effect of Lutein and Zeaxanthin (Lute-gen®) supplementation, with and without natural mixed carotenoids on central foveal thickness, and its relationship with macular pigment optical density (MPOD) in healthy adult subjects. A total of 93 subjects were randomized in a double-blind, placebo-controlled, parallel, three-arm study which was followed up for 180 days. Data obtained post the study period was subjected to advanced statistical analysis to determine the efficacy of Lutein and Zeaxanthin (Lute-gen®) with and without natural mixed carotenoids on central foveal thickness (CFT) and its relationship with MPOD to determine the physiological status of the eye health. Lutein and Zeaxanthin (Lute-gen®) supplementation, with natural mixed carotenoids (P=0.003) and without natural mixed carotenoids (P=0.012) showed statistically significant improvements in the CFT levels when compared to baseline. On the other hand, the placebo arm (P=0.11) did not show any significant change in CFT levels when CFT measurements were performed on both the eyes. Our study showed a significant positive correlation between MPOD and CFT suggesting MPOD is strongly correlated with CFT. These studies on the relationship between MPOD and CFT can contribute to a stronger understanding on the relationship between scavenging radicals and antioxidant activities of lutein, zeaxanthin and other mixed carotenoids on eye health.